Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 2/20 | 1.00 |
| ▸ | DGKA | P23743 | 1/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 7/20 | 0.58 |
| ▸ | PPARD | Q03181 | 7/20 | 0.58 |
| ▸ | PPARA | Q07869 | 7/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 5/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11345548 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL27957389 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL7773521 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL7775439 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL4725841 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL11354026 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL11047565 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL10555970 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL8671140 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL9602505 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0003794-B1 | TESTOSTERONE ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-01-28 | — | — | EP | claimed |
| CN-118234717-A | Bicyclic heteroaromatic compounds and their use as pest control agents | PI工业有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-116917283-A | Isoxazoline compounds and their use as pest control agents | 皮埃企业有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20230304002-A1 | TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES | BANK OF AMERICA, N.A. | 2023-09-28 | — | — | US | disclosed |
| US-20230272382-A1 | COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING COMPLEMENT COMPONENT C3-ASSOCIATED DISEASES | BANK OF AMERICA, N.A. | 2023-08-31 | — | — | US | disclosed |
| US-11161917-B2 | Method for producing cellulose derivative, and cellulose derivative | NEC CORPORATION (JP) | 2021-11-02 | — | — | US | disclosed |
| EP-3222156-B1 | FLAVOR IMPROVEMENT METHOD FOR YEAST CELLS AND FOOD QUALITY IMPROVING AGENT | TABLEMARK CO LTD (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-11089806-B2 | Flavor improvement method for yeast cells and food quality improving agent | TABLEMARK CO., LTD. (JP) | 2021-08-17 | — | — | US | disclosed |
| US-20190048099-A1 | METHOD FOR PRODUCING CELLULOSE DERIVATIVE, AND CELLULOSE DERIVATIVE | NEC CORPORATION (JP) | 2019-02-14 | — | — | US | disclosed |
| EP-2597156-B1 | METHOD FOR MANUFACTURING A FAT-SOLUBLE BIOACTIVE SUBSTANCE | KANEKA CORP (JP) | 2018-06-27 | — | — | EP | disclosed |
| US-4339389-A | POLYETHERS, POLYESTERS, POLYEPOXIDES | HENKEL CORPORATION (US) | 1982-07-13 | — | — | US | disclosed |
| US-4307224-A | POLYESTERS BASED ON BIS(HYDROXYMETHYL) OCTADECANOL | HENKEL CORPORATION (US) | 1981-12-22 | — | — | US | disclosed |
| US-4304945-A | High molecular weight products | HENKEL CORPORATION (US) | 1981-12-08 | — | — | US | disclosed |
| US-4243818-A | High molecular weight products | HENKEL CORPORATION (US) | 1981-01-06 | — | — | US | disclosed |
| US-4229562-A | CURABLE ELASTOMER PRODUCES MOLDABLE MICROCELLULAR FOAM | HENKEL CORPORATION (US) | 1980-10-21 | — | — | US | disclosed |
| EP-0017503-A2 | Gem-bis (hydroxymethyl) alcohols and mixtures thereof with diols, process for their preparation and a process for the preparation of polyurethanes therefrom | HENKEL CORPORATION (a Delaware corp.) (US) | 1980-10-15 | — | — | EP | disclosed |
| US-4216344-A | High molecular weight polyol mixtures | HENKEL CORPORATION (US) | 1980-08-05 | — | — | US | disclosed |
| US-4216343-A | High molecular weight polyhydric alcohols | HENKEL CORPORATION (US) | 1980-08-05 | — | — | US | disclosed |
| US-4066585-A | THERMOPLASTIC BINDERS | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-01-03 | — | — | US | disclosed |
| US-4059549-A | POLYURETHANE, ENAMINE | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230304002-A1 | TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES | TTR, MTPN, CRYAA | PAM 4870/4885DGKA 3847/4885GPR84 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.